Dose Safety, Tolerability, and Immunogenicity of a New Smallpox Vaccine in Adults Without Previous Smallpox Vaccination

This study has been terminated.

( CDC's decision to down-select vaccine development to single candidate, ACAM2000 )

Study NCT00053508 Information provided by Sanofi-Aventis

First Received: January 30, 2003 Last Updated: January 14, 2009 History of Changes

No Study Results Posted on ClinicalTrials.gov for this Study

Study Status:	This study has been terminated.
Study Completion Date:	September 2003
Primary Completion Date:	March 2003 (Final data collection date for primary outcome measure)